KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Common Equity (2016 - 2025)

Historic Common Equity for Cvs Health (CVS) over the last 17 years, with Q4 2025 value amounting to $75.4 billion.

  • Cvs Health's Common Equity fell 45.95% to $75.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $75.4 billion, marking a year-over-year decrease of 45.95%. This contributed to the annual value of $75.4 billion for FY2025, which is 45.95% down from last year.
  • According to the latest figures from Q4 2025, Cvs Health's Common Equity is $75.4 billion, which was down 45.95% from $73.1 billion recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Common Equity registered a high of $77.6 billion during Q2 2025, and its lowest value of $71.0 billion during Q3 2022.
  • Its 5-year average for Common Equity is $74.3 billion, with a median of $74.6 billion in 2021.
  • As far as peak fluctuations go, Cvs Health's Common Equity skyrocketed by 869.05% in 2021, and later plummeted by 483.4% in 2022.
  • Quarter analysis of 5 years shows Cvs Health's Common Equity stood at $74.8 billion in 2021, then dropped by 4.1% to $71.8 billion in 2022, then increased by 6.78% to $76.6 billion in 2023, then decreased by 1.18% to $75.7 billion in 2024, then fell by 0.46% to $75.4 billion in 2025.
  • Its Common Equity was $75.4 billion in Q4 2025, compared to $73.1 billion in Q3 2025 and $77.6 billion in Q2 2025.